These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13194421)

  • 61. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation.
    Atmuri V; Martin DC; Hemming R; Gutsol A; Byers S; Sahebjam S; Thliveris JA; Mort JS; Carmona E; Anderson JE; Dakshinamurti S; Triggs-Raine B
    Matrix Biol; 2008 Oct; 27(8):653-60. PubMed ID: 18762256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
    Girish KS; Kemparaju K
    Life Sci; 2007 May; 80(21):1921-43. PubMed ID: 17408700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms.
    Machiah DK; Girish KS; Gowda TV
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jun; 143(2):158-61. PubMed ID: 16513428
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.
    Andre P; Fléchet ML
    J Cosmet Dermatol; 2008 Jun; 7(2):136-8. PubMed ID: 18482018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Role of the hyaluronic acid-hyaluronidase system in pathological and normal physiology of the intercellular membranes].
    BILLERBECK K
    Zentralbl Allg Pathol; 1952 Aug; 89(3-4):63-6. PubMed ID: 13006931
    [No Abstract]   [Full Text] [Related]  

  • 66. The hyaluronan-protein complexes at low ionic strength: how the hyaluronidase activity is controlled by the bovine serum albumin.
    Lenormand H; Tranchepain F; Deschrevel B; Vincent JC
    Matrix Biol; 2009 Jul; 28(6):365-72. PubMed ID: 19394422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Participation of the hyaluronidase-hyaluronic acid system in blood clotting].
    Stepanian EP; Khrushchova VM; Golosovskaia MA
    Dokl Akad Nauk SSSR; 1966 May; 168(3):718-20. PubMed ID: 5994253
    [No Abstract]   [Full Text] [Related]  

  • 68. [Oligosaccharides as intermediary and end products in enzymatic degradation of hyaluronic acid].
    SCHUTTE E; GREILING H
    Hoppe Seylers Z Physiol Chem; 1955 Nov; 302(2-3):55-62. PubMed ID: 13306158
    [No Abstract]   [Full Text] [Related]  

  • 69. [Hyaluronic acid and hyaluronidase in the platelets].
    TROPEANO L; CACCIOLA E; MOTTA L
    Boll Soc Ital Biol Sper; 1956; 32(10-11):1249-51. PubMed ID: 13426295
    [No Abstract]   [Full Text] [Related]  

  • 70. [The hyaluronic acid-hyaluronidase system; clinical use of hyaluronidase in infusions].
    BOYENS H
    Ther Ggw; 1950 Jun; 89(6):169-77. PubMed ID: 15442987
    [No Abstract]   [Full Text] [Related]  

  • 71. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation.
    Oh EJ; Kang SW; Kim BS; Jiang G; Cho IH; Hahn SK
    J Biomed Mater Res A; 2008 Sep; 86(3):685-93. PubMed ID: 18022803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hyaluronic acid and hyaluronidase in blood platelets].
    TROPEANO L; CACCIOLA E; MOTTA L
    Haematologica; 1957; 42(7):807-14. PubMed ID: 13474479
    [No Abstract]   [Full Text] [Related]  

  • 73. Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes.
    Hertel W; Peschel G; Ozegowski JH; Müller PJ
    Arch Pharm (Weinheim); 2006 Jun; 339(6):313-8. PubMed ID: 16718670
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of the stability of magnetic fields on the acitvity of hyaluronidase and the structure of hyaluronic acie].
    Kitaev MI; Sydykov TS; Mamytova RM
    Zdravookhr Kirg; 1974; (5):18-20. PubMed ID: 4155570
    [No Abstract]   [Full Text] [Related]  

  • 75. Clinical and biochemical manifestations of hyaluronidase deficiency.
    Natowicz MR; Short MP; Wang Y; Dickersin GR; Gebhardt MC; Rosenthal DI; Sims KB; Rosenberg AE
    N Engl J Med; 1996 Oct; 335(14):1029-33. PubMed ID: 8793927
    [No Abstract]   [Full Text] [Related]  

  • 76. [Biochemical concepts of regeneration of vitreous body following experimental depolymerization of hyaluronic acid].
    Stankiewicz A; Szram S; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1237-42. PubMed ID: 1214435
    [No Abstract]   [Full Text] [Related]  

  • 77. Hyaluronidase and Restylane.
    Soparkar CN; Patrinely JR; Skibell BC; Tower RN
    Arch Facial Plast Surg; 2007; 9(4):299-300. PubMed ID: 17638770
    [No Abstract]   [Full Text] [Related]  

  • 78. [Problems in pathology concerning hyaluronic acid and its specific enzyme; hyaluronidase or mesomucinase].
    FAVILLI MG
    Rev Pathol Gen Physiol Clin; 1953 Feb; 53(645):273-7. PubMed ID: 13064580
    [No Abstract]   [Full Text] [Related]  

  • 79. [Medical significance of the hyaluronic acid-hyaluronidase system].
    MUNNICH A
    Dtsch Gesundheitsw; 1952 Nov; 7(47):1476-9. PubMed ID: 13043280
    [No Abstract]   [Full Text] [Related]  

  • 80. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization.
    Shimada M; Yanai Y; Okazaki T; Noma N; Kawashima I; Mori T; Richards JS
    Development; 2008 Jun; 135(11):2001-11. PubMed ID: 18434414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.